Mark Pruzanski, President & CEO at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 27,606 shares at $103.29 ($2.8M) on 2018-11-16, disclosed to the SEC on 2018-11-16.
Open-market sale of $2.8M ICPT by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.38 | 9,830 | $987K | 35.2% |
| 2 | $101.48 | 7,949 | $807K | 28.8% |
| 3 | $102.61 | 7,839 | $804K | 28.7% |
| 4 | $103.29 | 1,988 | $205K | 7.3% |
| Total | $101.54 avg | 27,606 | $2.8M | 100% |
| Filing → |
| ICPT | SELL | 2019-11-27 | $5.0M | — | Filing → |
| ICPT | SELL | 2018-11-16 | $9.1M | — | Filing → |
| ICPT | SELL | 2018-11-16 | $2.3M | — | Filing → |